Cargando…
Redox Imbalances in Ageing and Metabolic Alterations: Implications in Cancer and Cardiac Diseases. An Overview from the Working Group of Cardiotoxicity and Cardioprotection of the Italian Society of Cardiology (SIC)
Metabolic syndrome (MetS) is a well established risk factor for cardiovascular (CV) diseases. In addition, several studies indicate that MetS correlates with the increased risk of cancer in adults. The mechanisms linking MetS and cancer are not fully understood. Several risk factors involved in MetS...
Autores principales: | Mercurio, Valentina, Cuomo, Alessandra, Cadeddu Dessalvi, Christian, Deidda, Martino, Di Lisi, Daniela, Novo, Giuseppina, Manganaro, Roberta, Zito, Concetta, Santoro, Ciro, Ameri, Pietro, Spallarossa, Paolo, Arboscello, Eleonora, Tocchetti, Carlo Gabriele, Penna, Claudia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402085/ https://www.ncbi.nlm.nih.gov/pubmed/32708201 http://dx.doi.org/10.3390/antiox9070641 |
Ejemplares similares
-
Metabolomic Perspectives in Antiblastic Cardiotoxicity and Cardioprotection
por: Deidda, Martino, et al.
Publicado: (2019) -
A recommended practical approach to the management of anthracycline-based chemotherapy cardiotoxicity: an opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology
por: Spallarossa, Paolo, et al.
Publicado: (2016) -
A recommended practical approach to the management of target therapy and angiogenesis inhibitors cardiotoxicity: an opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology
por: Maurea, Nicola, et al.
Publicado: (2016) -
Metabolomic Profiles on Antiblastic Cardiotoxicity: New Perspectives for Early Diagnosis and Cardioprotection
por: Fazzini, Luca, et al.
Publicado: (2022) -
Antineoplastic Drug-Induced Cardiotoxicity: A Redox Perspective
por: Varricchi, Gilda, et al.
Publicado: (2018)